Could a single injection tame lupus and Sjögren's?
NCT ID NCT07751315
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This early-stage trial is evaluating an investigational drug called QLS2404, given as an injection, to see if it is safe and tolerable. The study first tests single doses in healthy volunteers, then moves to multiple doses in people with systemic lupus erythematosus or primary Sjögren's syndrome. Researchers will also look at how the drug moves through the body and whether it shows any signs of helping these autoimmune conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- QLS2404 injection
- What this could lead to
- If successful, this could point toward a new treatment option for autoimmune diseases like lupus and Sjögren's syndrome, potentially helping to control symptoms and reduce disease activity.
- What could go wrong
- This is an early-phase trial, so the main focus is safety, not effectiveness. The drug may not work as hoped, and side effects are possible. Results from this small study will need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SJÖGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic tame lupus flares?
- Can a single infusion tame tough lupus?
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.
- Can genetics and environment explain lupus in the gullah population?
- Can a pill tame Sjögren's? a new drug puts the immune system to the test
- Can a smartphone app bridge the lupus care gap for women of color?